Keysight Technologies Inc Stock News

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formula

Disappointing guidance sent the stock sharply lower today.

Keysight (KEYS) successfully navigated through macroeconomic uncertainty and moderate demand trends and registered a robust top-line expansion owing to its strong operating discipline and diverse port

Keysight (KEYS) successfully navigated through macroeconomic uncertainty and moderate demand trends and registered a robust top-line expansion owing to its strong operating discipline and diverse port

Disappointing guidance sent the stock sharply lower today.

Keysight Technologies Inc. KEYS, -13.71% shares were heading for their worst day on record Wednesday after the electronic design and test solutions company's forecast fell short of Wall Street expecta

Keysight (KEYS) delivered earnings and revenue surprises of 9.19% and 0.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Keysight Technologies Inc (NYSE: KEYS) shares are trading lower by 7% to $170 in Tuesday's after-hours session. The company reported first-quarter financial results and issued worse-than-expected F

Keysight Technologies, Inc. (NYSE:KEYS ) Q1 2023 Results Conference Call February 21, 2023 4:30 PM ET Company Participants Jason Kary - VP, Treasurer and IR Satish Dhanasekaran - President and CEO Nei

Keysight (KEYS) delivered earnings and revenue surprises of 9.19% and 0.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Keysight Technologies Inc. KEYS, -1.51% shares fell more than 7% in extended trading Tuesday after beating Wall Street estimates on first-quarter profit and revenue but falling short of expectations o

On CNBC’s "Halftime Report Final Trades," Requisite Capital Management's Bryn Talkington praised Devon Energy Corporation (NYSE: DVN) for its free cash flow. "Take advantage of the opportunity,"

Camtek (CAMT) delivered earnings and revenue surprises of 2.04% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Keysight's (KEYS) top-line performance in the first quarter of fiscal 2023 is likely to benefit from solid demand for its electronic design and test solutions and a robust 5G portfolio.